Tabuk Pharmaceuticals
Tabuk Pharmaceuticals, a leading player in the pharmaceutical industry, is headquartered in Saudi Arabia (SA) and operates extensively across the Middle East and North Africa. Founded in 1994, the company has established itself as a key provider of high-quality generic and branded medications, focusing on therapeutic areas such as cardiovascular, diabetes, and oncology. With a commitment to innovation, Tabuk Pharmaceuticals has developed a diverse portfolio of products that cater to the evolving healthcare needs of the region. The company is recognised for its robust manufacturing capabilities and adherence to international quality standards, positioning it as a trusted partner in the healthcare sector. Notable achievements include significant market share in various therapeutic segments, underscoring its reputation for excellence and reliability in pharmaceutical solutions.
DitchCarbon Score
How does Tabuk Pharmaceuticals's carbon action stack up? DitchCarbon scores companies based on their carbon action and commitment to reducing emissions. Read about our methodology to learn more.
Industry Average
Mean score of companies in the Medical Device Manufacturing industry. Comparing a company's score to the industry average can give you a sense of how well the company is doing compared to its peers.
Industry Benchmark
Tabuk Pharmaceuticals's score of 5 is lower than 81% of the industry. This can give you a sense of how well the company is doing compared to its peers.
Tabuk Pharmaceuticals's reported carbon emissions
Tabuk Pharmaceuticals, headquartered in Saudi Arabia, has committed to achieving net-zero carbon emissions by 2050. Although specific emissions data for the most recent year is not available, the company has set long-term targets under the Science Based Targets initiative (SBTi) to address emissions across all scopes. Starting in 2023, Tabuk Pharmaceuticals is actively working towards reducing its carbon footprint, demonstrating a commitment to sustainability within the pharmaceuticals, biotechnology, and life sciences sector. The company has pledged to implement strategies that align with global climate goals, although no specific reduction percentages have been disclosed. As part of its climate commitments, Tabuk Pharmaceuticals is focused on integrating sustainable practices into its operations, reflecting a growing trend in the industry towards environmental responsibility. The company's net-zero commitment underscores its dedication to mitigating climate change impacts and contributing to a more sustainable future.
Industry emissions intensity
Location emissions intensity
Reduction initiatives & disclosure networks
Companies disclose and commit to reducing emissions to show they are serious about reducing emissions impact over time. They can also help a company track its progress over time.
Tabuk Pharmaceuticals is committed to some reduction initiatives we track. This may change over time as the company engages with new initiatives or updates its commitments. DitchCarbon will update this information as it becomes available.
